- Report
- October 2025
- 160 Pages
Global
From €2833EUR$3,160USD£2,421GBP
€3542EUR$3,950USD£3,026GBP
- Report
- October 2025
- 160 Pages
Global
From €2833EUR$3,160USD£2,421GBP
€3542EUR$3,950USD£3,026GBP
- Report
- September 2025
- 205 Pages
Global
From €4479EUR$4,995USD£3,827GBP
- Report
- July 2026
- 160 Pages
Global
From €3721EUR$4,150USD£3,179GBP
- Report
- October 2025
- 160 Pages
Global
From €2833EUR$3,160USD£2,421GBP
€3542EUR$3,950USD£3,026GBP
- Report
- September 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,716GBP
- Report
- September 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,716GBP
- Report
- August 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,716GBP
- Report
- April 2026
- 91 Pages
Global
From €3500EUR$4,182USD£3,095GBP
- Report
- April 2026
- 99 Pages
Global
From €3500EUR$4,182USD£3,095GBP
- Report
- September 2025
- 101 Pages
Global
From €3500EUR$4,182USD£3,095GBP
- Report
- September 2025
- 89 Pages
Global
From €3500EUR$4,182USD£3,095GBP
- Report
- October 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,716GBP
- Report
- July 2026
- 120 Pages
Global
From €4349EUR$4,850USD£3,716GBP
- Report
- September 2025
- 140 Pages
Global
From €4349EUR$4,850USD£3,716GBP
- Report
- March 2026
- 88 Pages
North America
From €3093EUR$3,450USD£2,643GBP
- Report
- March 2026
- 80 Pages
Middle East, Africa
From €3093EUR$3,450USD£2,643GBP
- Report
- March 2026
- 107 Pages
Asia Pacific
From €3542EUR$3,950USD£3,026GBP
- Report
- March 2026
- 104 Pages
Europe
From €3542EUR$3,950USD£3,026GBP
- Report
- October 2025
- 89 Pages
United States
From €4035EUR$4,500USD£3,447GBP

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more